Humanigen Inc (HGENQ)

[DonDonDonDon]

Crazy that someone would sell right before data. I guess they're getting cold feet. Last Friday's plummet probably caused some to second guess. Hopefully, TLD comes this week as guided by management. I can't imagine anyone who has paid attention to the science is worried that data won't be game-changing.

The primary endpoint population of the ACTIV trial had 17.3% placebo mortality vs. 7.5% lenz mortality in the LIVE-AIR trial. There is still no effective immunomodulator authorized for newly hospitalized patients. Lenz should instantly become the most important Covid therapeutic as soon as it gets the EUA.